InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,446.68
(
0.00%
)
US TECH 100
17,942.00
(
-2.42%
)
Dow Jones
40,347.97
(
0.00%
)
Brent Oil
77.93
(
-2.56%
)
Bitcoin
64,738.54
(
-0.94%
)
Post# of 331335
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

kidnova

Send PM Follow Ignore
Followers 4
Posts 2219
Boards Moderated 0
Alias Born 10/15/2010

kidnova

Re: fuente post# 30190

Saturday, 05/18/2013 8:40:10 PM

Saturday, May 18, 2013 8:40:10 PM

Post# of 331335
That appears to be the case. I think best case short term is they get switched to IMJ and approved for prescription use. No matter what category they're in they'll likely need additional clinical trials for OTC.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM

Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM

VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM

Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM

Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM

Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!